Genmab reported DKK9.48B in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 969.12M 918.9M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
Amarin AMRN:US $ 327.02M 36.02M
Amgen AMGN:US $ 6630M 518M
AstraZeneca AZN:LN 15567M 7931M
Bayer BAYN:GR € 3389M 2161M
Biomarin Pharmaceutical BMRN:US $ 641.53M 25.78M
Bluebird Bio BLUE:US $ 353.47M 86.25M
Exelixis EXEL:US $ 492.46M 122.25M
Fresenius Medical Care FME:GR € 1408M 335M
Genmab GEN:DC DK 9477M 1585M
GlaxoSmithKline GSK:LN 3503M 1254M
GN Store Nord GN:DC DK 1715M 183M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 2M 321M
Immunogen IMGN:US $ 239.54M 43.58M
Insmed INSM:US $ 928.33M 518.58M
Lonza Group LONN:SW 501M 6M
Merck MRK:GR € 1825M 413M
Novartis NOVN:VX SF 5117M 1316M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M
Seattle Genetics SGEN:US $ 413.43M 39.72M